CVRx, Inc.
Every calculator, already run for CVRX
Open the full toolkit →You have the numbers on CVRX. Get the argument.
A written report on which of these readings actually decide the outcome for CVRx, Inc., what has to stay true for the price to work, and the specific thing that would break it. The first one is free.
Key market data
Analyst consensus
7 analysts covering CVRXAnalyst Price Target Disagreement for CVRx, Inc.
Wall Street's bull case implies +287% from the current price; the bear case implies +126%. A 161% spread signals high analyst disagreement — run your own DCF to anchor on fundamentals rather than street consensus.
Ownership & short interest
Insider Trading Activity for CVRX
| Insider | Role | Type | Shares | Price | Value | Date | Filing |
|---|---|---|---|---|---|---|---|
About CVRx, Inc.
CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offers Barostim, an implantable device that delivers electrical pulses to baroreceptors located in the wall of the carotid artery to counteract decreased baroreceptor signaling, and provides baroreflex activation therapy, which links the cardiovascular system to the autonomic nervous system. It sells its products through direct sales force, sales agents, and independent distributors. The company was incorporated in 2000 and is headquartered in Minneap…
CVRX — frequently asked
Is CVRX a buy right now?
Wall Street's consensus rating on CVRx, Inc. is Buy across 7 analysts, with a mean price target of $4.58 (+196% vs. the current $1.55). Ratings are a starting point — run the DCF and check the financial-health readings above before deciding.
When is CVRX's next earnings date?
CVRx, Inc. is next scheduled to report earnings around Nov 5, 2026. A full CVRX research report from Basis Report covers the setup into that print — estimates, the beat/miss record, and what would move the thesis.
What is the analyst price target disagreement for CVRx, Inc.?
Analysts covering CVRx, Inc. (CVRX) range from a bear-case target of $3.50 to a bull-case high of $6.00, with a mean consensus target of $4.58 across 6 analysts. The spread of $2.50 (161% of the current price) indicates high disagreement on the outlook. Run the DCF calculator to build your own estimate independent of street consensus.
Compare CVRx, Inc. against related stocks
Explore additional stock overview pages and jump directly into full report generation for each symbol.
Sector peers
Most-followed names in the same sector.
Nearby tickers
Additional public equities from our tracked universe.
Market leaders
Large-cap symbols investors frequently compare.
Investor Guides For CVRx, Inc.
Start with the evergreen guides that matter most for Healthcare, then move back into the ticker page when you want to pressure-test the framework on a live name.
Generate your full CVRX research report
DCF model, five-year financials, moat assessment, a BUY/HOLD/SELL rating, and the risks that matter — on CVRx, Inc., in minutes. 3 free reports included with every account — no credit card required.